At a glance
- Originator Rohm
- Class Antihypertensives; Heart failure therapies; Small molecules
- Mechanism of Action Potassium-sparing diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 03 Oct 2003 Discontinued - Preclinical for Heart failure in Germany (unspecified route)
- 03 Oct 2003 Discontinued - Preclinical for Hypertension in Germany (unspecified route)
- 09 Jun 1997 No-Development-Reported for Heart failure in Germany (Unknown route)